UY29861A1 - Uso de valerato de estradiol en combinación con dienogest para la terapia oral de la hemorragia uterina disfuncional unida con una anticoncepcion oral - Google Patents

Uso de valerato de estradiol en combinación con dienogest para la terapia oral de la hemorragia uterina disfuncional unida con una anticoncepcion oral

Info

Publication number
UY29861A1
UY29861A1 UY29861A UY29861A UY29861A1 UY 29861 A1 UY29861 A1 UY 29861A1 UY 29861 A UY29861 A UY 29861A UY 29861 A UY29861 A UY 29861A UY 29861 A1 UY29861 A1 UY 29861A1
Authority
UY
Uruguay
Prior art keywords
oral
combination
dienogest
dysfunctional uterine
hemorragy
Prior art date
Application number
UY29861A
Other languages
English (en)
Spanish (es)
Inventor
Holger Zimmermann
Angelo Secci
Jan Endrikat
Pol Boudes
Susan Zeun
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35811580&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY29861(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Ag filed Critical Schering Ag
Publication of UY29861A1 publication Critical patent/UY29861A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
UY29861A 2005-10-13 2006-10-13 Uso de valerato de estradiol en combinación con dienogest para la terapia oral de la hemorragia uterina disfuncional unida con una anticoncepcion oral UY29861A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05022324A EP1787649B1 (de) 2005-10-13 2005-10-13 Verwendung von Estradiolvalerat in Kombination mit Dienogest zur oralen Therapie der dysfunktionellen uterinen Blutung in Einheit mit einer oralen Kontrazeption

Publications (1)

Publication Number Publication Date
UY29861A1 true UY29861A1 (es) 2007-05-31

Family

ID=35811580

Family Applications (1)

Application Number Title Priority Date Filing Date
UY29861A UY29861A1 (es) 2005-10-13 2006-10-13 Uso de valerato de estradiol en combinación con dienogest para la terapia oral de la hemorragia uterina disfuncional unida con una anticoncepcion oral

Country Status (22)

Country Link
EP (2) EP1787649B1 (ru)
JP (2) JP5735200B2 (ru)
KR (2) KR101218872B1 (ru)
CN (1) CN101312733A (ru)
AR (1) AR056694A1 (ru)
AT (2) ATE424828T1 (ru)
CA (1) CA2623024C (ru)
CL (1) CL2011000283A1 (ru)
CY (2) CY1110321T1 (ru)
DE (2) DE502005006837D1 (ru)
DK (2) DK1787649T3 (ru)
DO (1) DOP2006000221A (ru)
ES (2) ES2322479T3 (ru)
HR (1) HRP20090256T1 (ru)
ME (1) ME01056B (ru)
PE (2) PE20100090A1 (ru)
PL (2) PL1787649T3 (ru)
PT (2) PT1787649E (ru)
SI (2) SI1787649T1 (ru)
TW (2) TWI328453B (ru)
UY (1) UY29861A1 (ru)
WO (1) WO2007042296A1 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004019743B4 (de) 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
ME01056B (me) * 2005-10-13 2012-10-20 Bayer Ip Gmbh Upotreba estradiolvalerata i dienogesta za oralno liječenje disfunkcionalnog uterinog krvarenja u kontracepcijskom metodu
US8153616B2 (en) 2005-10-17 2012-04-10 Bayer Pharma Aktiengesellschaft Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
EP1930010A1 (de) 2006-10-20 2008-06-11 Bayer Schering Pharma Aktiengesellschaft Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4429374C1 (de) * 1994-08-12 1996-02-01 Jenapharm Gmbh Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente
DE19540253C2 (de) * 1995-10-28 1998-06-04 Jenapharm Gmbh Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene
ATE249222T1 (de) * 1996-07-26 2003-09-15 Wyeth Corp Biphasische orale verhuetungsmethode und kit die eine kombination von progestin und eines oestrogens enthalten
US6251956B1 (en) 1998-08-20 2001-06-26 Ortho Pharmaceutical Corporation Combination progestin oral contraceptive regimen
EP1462106A1 (en) * 2003-03-28 2004-09-29 Pantarhei Bioscience B.V. Pharmaceutical compositions and kits comprising 17-beta-estradiol and a progesteron for the treatment of gynecological disorders
DE102004019743B4 (de) * 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
ME01056B (me) * 2005-10-13 2012-10-20 Bayer Ip Gmbh Upotreba estradiolvalerata i dienogesta za oralno liječenje disfunkcionalnog uterinog krvarenja u kontracepcijskom metodu

Also Published As

Publication number Publication date
CL2011000283A1 (es) 2011-07-08
EP1787649B1 (de) 2009-03-11
EP1933843A1 (de) 2008-06-25
CY1110321T1 (el) 2015-01-14
DK1933843T3 (da) 2011-04-18
HRP20090256T1 (en) 2009-06-30
TWI328453B (en) 2010-08-11
TW200731977A (en) 2007-09-01
ES2322479T3 (es) 2009-06-22
EP1787649A1 (de) 2007-05-23
SI1933843T1 (sl) 2011-06-30
DOP2006000221A (es) 2007-08-31
JP2009511526A (ja) 2009-03-19
ME01056B (me) 2012-10-20
ES2360302T3 (es) 2011-06-02
AR056694A1 (es) 2007-10-17
ATE497387T1 (de) 2011-02-15
SI1787649T1 (sl) 2009-08-31
PT1787649E (pt) 2009-05-08
CN101312733A (zh) 2008-11-26
KR20100082389A (ko) 2010-07-16
EP1933843B1 (de) 2011-02-02
ATE424828T1 (de) 2009-03-15
DK1787649T3 (da) 2009-06-02
PT1933843E (pt) 2011-04-29
JP5735200B2 (ja) 2015-06-17
CY1111406T1 (el) 2015-08-05
PE20100090A1 (es) 2010-03-12
DE502006008853D1 (de) 2011-03-17
CA2623024A1 (en) 2007-04-19
WO2007042296A1 (de) 2007-04-19
PE20070555A1 (es) 2007-07-12
KR101218872B1 (ko) 2013-01-07
PL1933843T3 (pl) 2011-06-30
CA2623024C (en) 2012-03-06
DE502005006837D1 (de) 2009-04-23
TW200829255A (en) 2008-07-16
JP2013047269A (ja) 2013-03-07
PL1787649T3 (pl) 2009-08-31
KR20080065651A (ko) 2008-07-14

Similar Documents

Publication Publication Date Title
EA200900491A1 (ru) Применение эстрадиола валерата или 17в-эстрадиола в комбинации с диеногестом для перорального лечения для поддержания и/или повышения полового влечения у особи женского пола
ECSP088123A (es) Anticoncepcion oral con trimegestona
NO20062945L (no) Forlenget anvendelseskombinasjon omfattende ostrogener og progestiner
AR048722A1 (es) Tratamiento de la hemorragia de disrupcion en regimenes anticonceptivos extendidos
DK0836506T4 (da) Transdermalt plaster til indgivelse af 17-deacetyl norgestimat alene eller i kombination med et østrogen
AR049112A1 (es) Composiciones, metodos y kit, para el tratamiento de trastorno disforico premenstrual
CR7611A (es) Uso de derivados de cilotiocarbamato en tratamiento de condiciones relacionadas con la hormona
AR065816A1 (es) Regimen anticonceptivo oral
UY29861A1 (es) Uso de valerato de estradiol en combinación con dienogest para la terapia oral de la hemorragia uterina disfuncional unida con una anticoncepcion oral
CR8010A (es) Regimenes de contraceptivos transdermicos extendidos
CO5690602A2 (es) Regimenes anticonceptivos trifasicos extendidos
JP2013047269A5 (ru)
AR049195A1 (es) Uso de una combinacion de etinilestradiol y acetato de clormadinona para la preparacion de un medicamento
DOP2006000035A (es) Preparación farmaceútica para la anticoncepción oral
PE20070769A1 (es) Procedimiento para la produccion de una preparacion farmaceutica monofasica para la terapia oral de la hemorragia uterina disfuncional
AR039227A1 (es) Terapia de reemplazo hormonal
DOP2010000017A (es) Estratrienos 8-beta-sustituidos como estrogenos de accion selectiva
CY1112775T1 (el) Χρηση βαλεριανικης οιστραδιολης σε συνδυασμο με dienogest για την απο του στοματος θεραπεια της δυσλειτουργικης αιμορραγιας της μητρας σε ενοτητα με αντισυλληψη απο του στοματος
ECSP034606A (es) Uso de antiprogestinas para la induccion de apoptosis en una celula
AR049220A1 (es) Uso de 7-ter-butoxiiminometilcamptotecina en la preparacion de un medicamento util para el tratamiento de neoplasmas uterinos
DOP2007000122A (es) Forma farmacologica peroral para anticoncepcion
AR056674A1 (es) Anticoncepcion oral con trimegestona
AR039477A1 (es) Terapia de reemplazo hormonal
CL2023000450A1 (es) Nueva composición de anticonceptivo oral de liberación modificada
PE20091020A1 (es) Uso de un gestageno en combinacion con un estrogeno y uno o varios excipientes/portadores farmaceuticamente aceptables para la anticoncepcion oral sin lactosa

Legal Events

Date Code Title Description
RDES Application refused

Effective date: 20190228